Showing 911-920 of 2783 results for "".
Assessing the Interplay of Sleep, Hormones, and Depression
https://practicalneurology.com/diseases-diagnoses/sleep/assessing-the-interplay-of-sleep-hormones-and-depression/30685/As research continues, new directions in therapy appear to be emerging.TIME OUT: A Case-Based Deep Dive into the Challenges of ARIA Management
https://practicalneurology.com/programs/cme/time-out-a-case-based-deep-dive-into-the-challenges-of-aria-management/26588/Enhance your expertise in acute ARIA management with "Time Out," a case-based deep dive into real-world challenges in Alzheimer's care.The Benefits of Application Service Providers
https://practicalneurology.com/columns/practice-management/PN1009_04-php/30881/As the details of healthcare reform take shape, an ASP may provide a cost-efficient way for clinicians to go digital.- American Idle: Spotlighting the Obstacles That Deter Migraine Preventionhttps://practicalneurology.com/diseases-diagnoses/headache-pain/pn0307-migraine-pdf/31202/Bridging the Gap in Preventive Migraine Therapy: Insights and StrategiesPreventive migraine therapy remains significantly underutilized, despite evidence indicating that a substantial proportion of migraine sufferers could benefit from it. The American Migraine Prevalence and Prevention Study by Lip
- Movement Disorders Focushttps://practicalneurology.com/diseases-diagnoses/movement-disorders/pn0307-movedisorders-pdf/31203/Accurate assessment of movement disorders is crucial for clinicians to quantify their impact on patients’ quality of life and monitor disease progression. Practical Neurology’s recent article delves into various validated rating scales tailored for specific neurological conditions, enhancing objecti
Drugs in Development for Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/drugs-in-development-for-multiple-sclerosis/31632/Stem cells, tyrosine kinase inhibitors, remyelinating agents, metabolically active molecules, and more are being tested as potential new disease-modifying treatments.Aches and Trauma: Understanding Post-Traumatic Headache, Part 2: Management and Treatment
https://practicalneurology.com/diseases-diagnoses/tbi/aches-and-trauma-understanding-post-traumatic-headache-part-2-management-and-treatment/30331/Despite limited options for the treatment of post-traumatic headache, some evidence suggests potential for select therapies.In the Pipeline: Nasal Oxytocin Explored for Migraines
https://practicalneurology.com/diseases-diagnoses/headache-pain/in-the-pipeline-nasal-oxytocin-explored-for-migraines/30727/Can migraine patients trust the “trust drug” to heal their pain?LGI1 Antibody Encephalitis Presenting as Focal Cortical Encephalitis
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/lgi1-antibody-encephalitis-presenting-as-focal-cortical-encephalitis-1/32135/Individuals with LGI1 antibody encephalitis may present with atypical symptoms, requiring a comprehensive diagnostic work-up and vigilance by clinicians.Chronic Inflammatory Demyelinating Polyneuropathy
https://practicalneurology.com/diseases-diagnoses/headache-pain/chronic-inflammatory-demyelinating-polyneuropathy/31813/Updates in diagnosis and management.